At close: December 16 at 4:00:02 PM EST
After hours: December 16 at 4:01:44 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
163,098.00
182,833.00
43,039.00
Total Liabilities Net Minority Interest
316,291.00
267,942.00
1,818.00
Total Equity Gross Minority Interest
-153,193.00
-85,109.00
41,221.00
Total Capitalization
-153,193.00
-85,109.00
41,221.00
Preferred Stock Equity
--
--
89,865.00
Common Stock Equity
-153,193.00
-85,109.00
-48,644.00
Capital Lease Obligations
317.00
139.00
--
Net Tangible Assets
-153,193.00
-85,109.00
41,221.00
Working Capital
148,344.00
174,262.00
41,134.00
Invested Capital
-153,193.00
-85,109.00
-48,644.00
Tangible Book Value
-153,193.00
-85,109.00
-48,644.00
Total Debt
317.00
139.00
--
Share Issued
31,956.66
31,956.66
31,956.66
Ordinary Shares Number
31,956.66
31,956.66
31,956.66
12/31/2021 - 1/26/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANRO Alto Neuroscience, Inc.
3.7500
-2.09%
KYTX Kyverna Therapeutics, Inc.
4.2400
-4.07%
GUTS Fractyl Health, Inc.
2.1100
+3.43%
APGE Apogee Therapeutics, Inc.
47.21
+6.09%
DNTH Dianthus Therapeutics, Inc.
24.03
+0.92%
CGON CG Oncology, Inc.
29.21
+1.56%
TYRA Tyra Biosciences, Inc.
15.06
+0.80%
SYRE Spyre Therapeutics, Inc.
24.42
+1.24%
MBX MBX Biosciences, Inc.
19.14
+1.06%
LXEO Lexeo Therapeutics, Inc.
7.08
+2.91%